2025 has been an extraordinary year of momentum at the Lupus Research Alliance and clinical affiliate Lupus Therapeutics. Hear from Lupus Research Alliance President & CEO Albert T. Roy about how – thanks to your generous support – we continue to advance innovative research, getting us closer to a world free of lupus.
From funded explorations into gut health and lupus, digging into the promising field of engineered cell therapy, and working alongside incredible partners like allied disease nonprofits, pharmaceutical companies, and the U.S. Food and Drug Administration, each activity has kept people living with lupus at the center.
As Mr. Roy emphasizes, every step forward is made possible by you. We look forward to continuing progress together in the year ahead.
